Medical drapes, devices, and systems employing a holographically-formed polymer dispersed liquid crystal (H-PDLC) device
A reduced-pressure medical treatment system for treating a tissue site on a patient includes a medical drape that has an holographically-formed polymer dispersed liquid crystal (H-PDLC) device that changes visual appearance when experiencing strain. The change in visual appearance of the H-PDLC device allows identification of the existence of strain and may allow a quantitative assessment of the range of stress involved. In other aspects, a dressing conduit connector, canister, and reduced-pressure interface use a holographically-formed polymer dispersed liquid crystal (H-PDLC) device to help determine the existence and perhaps the amount of stress experienced. Other systems, methods, and devices are presented.
1. A reduced-pressure treatment system for treating a tissue site, the system comprising:
a distribution manifold for disposing proximate to the tissue site;
a drape for covering the distribution manifold and a portion of intact skin to form a sealed space; and
a reduced-pressure source fluidly coupled to the sealed space;
wherein the drape comprises a holographically-formed polymer dispersed liquid crystal (H-PDLC) device having layers of liquid crystal (LC) droplets in a matrix polymer.
2. The system of claim 1 , wherein the H-PDLC device covers a window frame.
3. The system of claim 1 , wherein the H-PDLC device is operable to change colors when a desired pressure range in the sealed space exists.
4. The system of claim 1 , wherein the drape comprises a plurality of laminated polymer layers and wherein the H-PDLC device is disposed between at least two of the plurality of laminated polymer layers.
5. The system of claim 4 , further comprising a reflective layer disposed on a tissue-facing side of the H-PDLC device to reflect light back through the H-PDLC device.
6. The system of claim 1 , wherein the H-PDLC device comprises a plurality of strips attached to a polymer layer.
7. The system of claim 1 , wherein the H-PDLC device comprises a grid attached to a polymer layer.
8. The system of claim 6 , wherein the H-PDLC device covers 50 percent or less of a surface area of the drape.
9. A method for treating a tissue site with reduced pressure, the method comprising:
disposing a distribution manifold proximate to the tissue site;
covering the distribution manifold and a portion of intact skin with a drape to form a sealed space, wherein the drape comprises a holographically-formed polymer dispersed liquid crystal (H-PDLC) device;
delivering reduced pressure to the sealed space; and
monitoring the drape for any changes in visual appearance in the H-PDLC device.
10. The method of claim 9 , wherein the step of monitoring comprises using a photodiode, a spectrometer for observing a wavelength shift, or an analyzer for observing a polarization-dependent shift in the reflected light.
11. A drape for covering a tissue site, the drape comprising:
a first polymer layer;
a second polymer layer; and
a holographically-formed polymer dispersed liquid crystal (H-PDLC) device having layers of liquid crystal (LC) droplets in a matrix polymer disposed between the first polymer layer and the second polymer layer; and
an attachment device coupled to a portion of the drape adapted for removably coupling the drape to skin proximate to the tissue site.
12. The drape of claim 11 , further comprising a non-conformable window frame and the H-PDLC device covers at least a portion of the non-conformable window frame.
13. The drape of claim 11 , further comprising a plurality of pressure-indicating devices, wherein each of the pressure-indicating devices comprises a window covered by the H-PDLC device, and wherein each of the plurality of pressure-indicating devices is adapted to change visual appearances over a different pressure range.
14. The drape of claim 11 , wherein the H-PDLC device comprises a plurality of spaced strips and wherein the spaced strips are disposed on a polymer layer of the drape.
15. The drape of claim 11 , wherein the H-PDLC device comprises a grid on a polymer layer.
16. The drape of claim 11 , wherein the H-PDLC device covers 50 percent or less of a surface area of the drape.
17. A reduced-pressure interface for providing reduced pressure to a tissue site, the reduced-pressure interface comprising:
an interface body;
a conduit opening for coupling to a reduced-pressure delivery conduit, a delivery opening for communicating reduced pressure to the tissue site, and a passageway fluidly coupling the conduit opening and the delivery opening through the interface body; and
wherein the interface body comprises a holographically-formed polymer dispersed liquid crystal (H-PDLC) device having layers of liquid crystal (LC) droplets in a matrix polymer.
18. The reduced-pressure interface of claim 17 , wherein the interface body further comprises a base and a portion of the base comprises the H-PDLC device.
19. The reduced-pressure interface of claim 17 , wherein the interface body further comprises a suction head and a portion of the suction head comprises the H-PDLC device.
20. The reduced-pressure interface of claim 17 , further comprising:
a chamber wall forming a chamber and having a window formed on the chamber wall;
wherein the window is covered by the H-PDLC device to form a pressure-indicating device; and
wherein the interface body is formed with a passageway having an aperture that fluidly couples the passageway and the chamber.
21. A canister for receiving body fluids, the canister comprising:
a canister body forming a fluid reservoir;
an inlet formed on the canister body for receiving a reduced-pressure delivery conduit;
a window frame formed on the canister body;
a holographically-formed polymer dispersed liquid crystal (H-PDLC) device covering the window frame; and
wherein the H-PDLC device is adapted to change visual appearances when experiencing strain within a first range.
22. The canister of claim 21 , further comprising a plurality of pressure-indicating devices, wherein the window frame comprises at least one of the plurality of pressure-indicating devices, and wherein at least two of the pressure-indicating devices of the plurality of pressure-indicating devices change visual appearances for strains of different magnitudes.
23. The canister of claim 21 , wherein the window frame is a non-conformable window frame indicating a pressure range associated with a magnitude of strain over which the H-PDLC device changes visual appearances.
24. A conduit connector for connecting medical conduits, the conduit connector comprising:
a chamber in a connector body,
an inlet fluidly coupled to the chamber for receiving a first conduit, and
an outlet fluidly coupled to the chamber for receiving a second conduit; and
a pressure-indicating device formed on the connector body, wherein the pressure-indicating device comprises a window frame covered by a holographically-formed polymer dispersed liquid crystal (H-PDLC) device.
25. A method for treating a wound, the method comprising:
covering the wound with a drape, wherein the drape comprises a holographically-formed polymer dispersed liquid crystal (H-PDLC) device having layers of liquid crystal (LC) droplets in a matrix polymer and wherein the drape is configured to change visual appearance when subjected to a strain greater than a threshold strain; and
confirming that that the drape has not experienced a change in visual appearance indicative of a strain greater than the threshold strain.
26. The method of claim 25 , further comprising disposing a wound filler on the wound.